D'Antonio F, Khalil A, Garel C, Pilu G, Rizzo G, Lerman-Sagie T, Bhide A, Thilaganathan B, Manzoli L, Papageorghiou A T
Fetal Medicine Unit, Division of Developmental Sciences, St George's University of London, London, UK.
Hôpital d'Enfants Armand-Trousseau - Service de Radiologie, Cedex 12, Paris, France.
Ultrasound Obstet Gynecol. 2016 Jul;48(1):28-37. doi: 10.1002/uog.15755.
Diagnosis of isolated posterior fossa anomalies in children is biased by the fact that only those that are symptomatic are brought to the attention of the appropriate clinical personnel, and the reported rate is often affected by the adoption of different nomenclature, diagnostic criteria, outcome measures, duration of follow-up and neurodevelopmental tools. The aim of this systematic review was to explore the neurodevelopmental outcome of fetuses with a prenatal diagnosis of isolated posterior fossa anomalies.
MEDLINE and EMBASE were searched electronically, utilizing combinations of the relevant medical subject heading terms for 'posterior fossa' and 'outcome'. Studies assessing the neurodevelopmental outcome in children with a prenatal diagnosis of isolated posterior fossa malformations were considered eligible. The posterior fossa anomalies analyzed included Dandy-Walker malformation (DWM), mega cisterna magna (MCM), Blake's pouch cyst (BPC) and vermian hypoplasia (VH). Two authors reviewed all abstracts independently. Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale for cohort studies. Meta-analyses of proportions were used to combine data, and between-study heterogeneity was explored using the I(2) statistic.
A total of 1640 articles were identified; 95 were assessed for eligibility and a total of 16 studies were included in the systematic review. The overall rate of abnormal neurodevelopmental outcome in children with a prenatal diagnosis of DWM was 58.2% (95% CI, 21.8-90.0%) and varied from 0-100%. In those with a prenatal diagnosis of MCM, the rate of abnormal neurodevelopmental outcome was 13.8% (95% CI, 7.3-21.9%), with a range of 0-50%. There was no significant association between BPC and the occurrence of abnormal neurodevelopmental delay, with a rate of 4.7% (95% CI, 0.7-12.1%) and range of 0-5%. Although affected by the very small number of studies, there was a non-significant occurrence of abnormal neurodevelopmental delay in children with a prenatal diagnosis of VH, with a rate of 30.7% (95% CI, 0.6-79.1%) and range of 0-100%.
Fetuses diagnosed with isolated DWM are at high risk of abnormal neurodevelopmental outcome, while isolated MCM or BPC have a generally favorable outcome. The risk of abnormal developmental delay in cases with isolated VH needs to be further assessed. In view of the wide heterogeneity in study design, time of follow-up, neurodevelopmental tests used and the very small number of included cases, further future large prospective studies with standardized and objective protocols for diagnosis and follow-up are needed in order to ascertain the rate of abnormal neurodevelopmental outcome in children with isolated posterior fossa anomalies. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.
儿童孤立性后颅窝异常的诊断存在偏差,因为只有出现症状的病例才会引起相关临床人员的注意,而且报告的发病率常常受到不同命名法、诊断标准、结局指标、随访时长以及神经发育评估工具的影响。本系统评价的目的是探讨产前诊断为孤立性后颅窝异常的胎儿的神经发育结局。
通过电子检索MEDLINE和EMBASE,使用“后颅窝”和“结局”的相关医学主题词组合。评估产前诊断为孤立性后颅窝畸形儿童神经发育结局的研究被视为合格。分析的后颅窝异常包括丹迪-沃克畸形(DWM)、巨大枕大池(MCM)、 Blake囊肿(BPC)和小脑蚓部发育不全(VH)。两位作者独立审阅所有摘要。使用纽卡斯尔-渥太华量表对纳入研究进行质量评估。采用比例的荟萃分析合并数据,并使用I²统计量探讨研究间的异质性。
共检索到1640篇文章;95篇文章进行了资格评估,16项研究纳入了系统评价。产前诊断为DWM的儿童神经发育异常结局的总体发生率为58.2%(95%CI,21.8 - 90.0%),范围为0 - 100%。产前诊断为MCM的儿童,神经发育异常结局的发生率为13.8%(95%CI,7.3 - 21.9%),范围为0 - 50%。BPC与神经发育延迟异常的发生无显著关联,发生率为4.7%(95%CI,0.7 - 12.1%),范围为0 - 5%。尽管受研究数量极少的影响,产前诊断为VH的儿童神经发育延迟异常的发生率无统计学意义,为30.7%(95%CI,0.6 - 79.1%),范围为0 - 100%。
产前诊断为孤立性DWM的胎儿神经发育异常结局风险高,而孤立性MCM或BPC的结局总体较好。孤立性VH病例发育延迟异常的风险需要进一步评估。鉴于研究设计、随访时间、使用的神经发育测试方法存在广泛异质性,且纳入病例数量极少,未来需要进一步开展大型前瞻性研究,采用标准化、客观的诊断和随访方案,以确定孤立性后颅窝异常儿童神经发育异常结局的发生率。版权所有©2015国际妇产科超声学会。由约翰·威利父子有限公司出版。